The tumor suppressor gene VHL could be inactivated by somatic mutation, deletion or hypermethylation in most ccRCC patients is and associated with tumorigenesis at the earliest stage of the disease 2. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.